Veracyte, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (4)

Latest Posts

About This Stock More About This Stock
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
Article By: Rod Raynovich
Sunday, February 5, 2023 8:10 PM EST
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
In this article: NTLA, IBB, PACB, XBI, SUPN, CRSP, ARKG, VCYT Also: CYRX, GERN, QDEL, HOLX, VRTX, EXAS, EVH, NVTA, TDOC
Read
Small Cap Biotech Stocks Are Trending Well
Article By: Rod Raynovich
Monday, July 18, 2022 4:14 AM EST
Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx.
In this article: REGN, PACB, EXAS, XBI, MRNA, TDOC, CRSP, ARKG, VCYT
Read
Mid-Cap Biotech Picks: Seasonal Rally Underway
Article By: Rod Raynovich
Saturday, July 3, 2021 6:54 PM EST
Many Mid-Cap biotech stocks were hit hard after the February peak. We suggest three new mid-cap biotech picks. All three picks can be volatile but very tradable.
In this article: CYRX, CRSP, VCYT Also: ARKG, XBI
Read
5 Stocks That Make Ark Innovation ETF (ARKK) Red Hot
Article By: Sweta Killa
Friday, February 19, 2021 7:39 AM EST
Ark Investment Management founder Cathie Wood has been seeing massive money flowing into five of the seven ETFs lineup in recent months.
In this article: PACB, SSYS, TSLA, ARKK, TDOC, HUYA, VCYT Also: VOO
Read
Veracyte - Chart Of The Day
Article By: Jim Van Meerten
Wednesday, December 2, 2020 12:11 PM EST
Revenue expected to grow 32.10% next year. Earnings estimated to increase 49.20% next year.
In this article: VCYT
Read

Latest Tweets for $VCYT

No tweets yet!

PARTNER HEADLINES